Nutriband extends credit line to $5m as it aims for FDA approval

Pharma firm led by Gareth Sheridan optimistic it can secure approval in early 2024 for groundbreaking drug patch

Gareth Sheridan, founder and chief executive, Nutriband: ‘What we’re doing is creating a whole new standard in terms of dealing with opiates misuse’